logo

For the Inventor, By the Inventor

Gainesville, FL, United States of America

Shifeng Wang

This inventor holds 10 USPTO granted patents and 4 published patent applications. Top assignees: Arizona State University, Washington University, University of Florida Research Foundation Inc.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shifeng Wang. Retrieved from https://idiyas.com/inventor/shifeng-wang-nk972trs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Tempe, AZ (US) (2013 - 2016)
  • Gainesville, FL (US) (2018 - 2024)

Company Filing History:

goldMedal6 out of 2,166 
 
Arizona State University
 patents
silverMedal6 out of 1,383 
 
Washington University
 patents
bronzeMedal3 out of 3,056 
 
University of Florida Research Foundation Inc.
 patents
4. 1 out of 3,697 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...
10 patents (USPTO):Explore Patents
1. 11920139 - Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety (2024-03-05),
2. 11788056 - Induction of protective immunity against antigens (2023-10-17),
3. 11596677 - Induction of protective immunity against antigens (2023-03-07),
4. 11180765 - Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety (2021-11-23),
5. 10988729 - Induction of protective immunity against antigens (2021-04-27),
6. 10774334 - Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety (2020-09-15),
7. 9885051 - Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety (2018-02-06),
8. 9297015 - Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety (2016-03-29),
9. 9050285 - [object Object] (2015-06-09),
10. 8445254 - Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety (2013-05-21),

Title: Innovations and Contributions of Inventor Shifeng Wang

Introduction

Shifeng Wang is a prominent inventor based in Gainesville, FL (US), known for his significant contributions to the field of vaccine development. With a total of 10 patents to his name, Wang has made remarkable strides in enhancing vaccine immunogenicity and safety through innovative methodologies.

Latest Patents

Among his latest patents, Wang has developed compositions and methods for making and using recombinant bacteria capable of regulated attenuation and/or regulated expression of one or more antigens of interest. His inventions, such as "Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety" and "Induction of protective immunity against antigens," showcase his commitment to advancing vaccine technology.

Career Highlights

Wang has had a distinguished career, working with esteemed institutions such as Arizona State University and Washington University. His work has focused on the intersection of microbiology and immunology, leading to groundbreaking advancements in vaccine research.

Collaborations

Throughout his career, Wang has collaborated with notable colleagues, including Roy Curtiss III and Soo-Young Wanda. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Shifeng Wang's contributions to vaccine development through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the future of immunology and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…